How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Non-PVC IV Solution Bags Market
- By Material Composition: Polyolefin (PO), Ethylene Vinyl Acetate (EVA), Polyethylene (PE), Polypropylene (PP), Thermoplastic Elastomers (TPE)
- By Application: Parenteral Nutrition, Blood and Blood Components, Pharmaceutical Solutions, Electrolyte Solutions, Glucose Solutions
- By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Home Healthcare Settings, Diagnostic Laboratories
- By Bag Capacity: 50 mL, 100 mL, 250 mL, 500 mL, 1000 mL
- By Closure Type: Spike Port, Luer Lock Port, Screw Cap, Pierceable Seal
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Polyolefin (PO) leads By Material Composition at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Non-PVC IV Solution Bags Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Material Composition 5
Application 5
End User 5
Bag Capacity 5
Closure Type 4
Companies profiled
B. Braun Melsungen AG
Fresenius Kabi
Baxter International Inc.
Nipro Corporation
Terumo Corporation
Noble International Ltd.
Sino Medical Sciences Technology Inc.
Hospira (a Pfizer company)
Sungwon Medical Co. Ltd.
Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Ningbo David Medical Device Co. Ltd.
Medline Industries Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →B. Braun Melsungen AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Fresenius Kabi
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Nipro Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Noble International Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Sino Medical Sciences Technology Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Hospira (a Pfizer company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sungwon Medical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Ningbo David Medical Device Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Medline Industries Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Becton
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Dickinson and Company (BD)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Smiths Medical (part of ICU Medical)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Braun Medical Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,366M by 2033 · 3.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polyolefin (PO)46.8
- Ethylene Vinyl Acetate (EVA)19.5
- Polyethylene (PE)16.9
- Polypropylene (PP)7.2
- Thermoplastic Elastomers (TPE)9.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,599M → $2,298M · 4.6%
Europe$1,114M → $1,413M · 3.0%
Asia Pacific$1,017M → $1,391M · 4.0%
Latin America$629.8M → $844.9M · 3.7%
Middle East and Africa$484.5M → $651.7M · 3.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.422026
3.442027
3.442028
3.462029
3.482030
3.482031
3.512032
3.502033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- B. Braun Melsungen AG25.3
- Fresenius Kabi18.3
- Baxter International Inc.7.9
- Nipro Corporation7.8
- Terumo Corporation7.4
- Noble International Ltd.5.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Composition20.2%
Application26.9%
End User8.7%
Bag Capacity25.1%
Closure Type19.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.8
- Europe21.4
- Asia Pacific21.1
- Latin America12.8
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| B. Braun Melsungen AG | 84 | 82 | 96 | 95 | 90 | 86 | 89 |
| Fresenius Kabi | 84 | 79 | 92 | 82 | 72 | 87 | 83 |
| Baxter International Inc. | 69 | 86 | 84 | 70 | 87 | 86 | 80 |
| Nipro Corporation | 64 | 70 | 69 | 81 | 77 | 77 | 73 |
| Terumo Corporation | 71 | 55 | 71 | 65 | 52 | 55 | 62 |
| Noble International Ltd. | 50 | 49 | 71 | 61 | 50 | 49 | 55 |
| Sino Medical Sciences Technology Inc. | 61 | 52 | 54 | 51 | 42 | 56 | 53 |
| Hospira (a Pfizer company) | 45 | 59 | 56 | 51 | 54 | 38 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- B. Braun Melsungen AG
- Fresenius Kabi
- Baxter International Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| B. Braun Melsungen AG | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Fresenius Kabi | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Baxter International Inc. | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Nipro Corporation | − | ✓ | ◐ | ◐ | ✓ | ◐ |
| Terumo Corporation | ✓ | ◐ | ◐ | − | − | − |
| Noble International Ltd. | − | − | − | ◐ | − | − |
| Sino Medical Sciences Technology Inc. | ✓ | ◐ | ◐ | ◐ | − | ◐ |
| Hospira (a Pfizer company) | ◐ | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1B. Braun Melsungen AG89
2Fresenius Kabi83
3Baxter International Inc.80
4Nipro Corporation73
5Terumo Corporation62
6Noble International Ltd.55
7Sino Medical Sciences Technology Inc.53
8Hospira (a Pfizer company)51
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
B. Braun Melsungen AGFresenius KabiBaxter International Inc.
Challenger1
Strong scale, closing on the leaders.
Nipro Corporation
Contender1
Focused players with pockets of strength.
Terumo Corporation
Niche3
Specialists in a single segment or region.
Noble International Ltd.Sino Medical Sciences Technology Inc.Hospira (a Pfizer company)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Composition in North America, then scale across Non-PVC IV Solution Bags Market — a $755M beachhead inside a $11.3B market.
Beachhead (SOM)$755Mobtainable near-term
Serviceable (SAM)$4.17Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Polyolefin (PO)
Best fit — highest urgency & budget in Material Composition.
Economic buyer76 fit
Ethylene Vinyl Acetate (EVA)
Strong fit — clear ROI and a fast path to value.
End user69 fit
Polyethylene (PE)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Composition in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel30%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Material Composition leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Non-PVC IV Solution Bags Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified23%
Evaluation13%
Closed-won5%
$14.3KCAC
$60KLTV
4.2:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Non-PVC IV Solution Bags Market is a high-growth opportunity — $10.4B by 2033, compounding at 11.0%.
TAM · 2025$4.53Btoday
TAM · 2033$10.4Bforecast
CAGR11.0%2027–2033
Cumulative$64.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.4BTotal addressable market
SAM$4.36BServiceable available market
SOM$900MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.0% CAGR
Demand compounds through 2033, outpacing GDP across Material Composition.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Composition moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.4BLarge & growingTAM by 2033 at 11.0% CAGR
$4.36BServiceable nowreachable with today’s model
$900MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.13BBear7.1% CAGR
$10.4BBase11.0% CAGR
$13.3BBull14.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Non-PVC IV Solution Bags Market — a $704M market by 2033. Plan: grow share from 8.0% to 13.4%.
Market size · 2033$704Mtotal addressable
Market CAGR7.0%2027–2033
Target share13.4%from 8.0% today
Revenue ambition$94Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.0% | 13.4% | Behind |
| Revenue | $52M | $94M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 34.3% | 39.9% | Behind |
| Customer retention | 86.8% | 95.2% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Composition
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Composition share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $10M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Material Composition leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Non-PVC IV Solution Bags Market conversation — a $1.08B market you can size, segment and defend in minutes.
Market size · 2033$1.08Btotal opportunity
Growth4.1%CAGR to 2033
Addressable buyers1,656+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Composition
Goal Grow share in Material Composition
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 3 mopayback period
$90K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
B. Braun Melsungen AGFresenius KabiBaxter International Inc.Nipro CorporationTerumo CorporationNoble International Ltd.Sino Medical Sciences Technology Inc.Hospira (a Pfizer company)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Non-PVC IV Solution Bags Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Non-PVC IV Solution Bags Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Non-PVC IV Fluid Bags Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportNon-PVC High-Volume Infusion Bags Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportNon-PVC Film Soft Bag Infusion Production Line Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportNon-PVC Film for IV Bags Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportNon-Profit Medical Consulting Services Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportNon-prestained Protein Standard Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportNon-prescription Mouthwashes Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportNon-prescription Mouthrinse Market
Market size, share, segmentation and regional forecast.
$956M market · 2025 base year
View reportNon-Powdered Surgical Gloves Market
Market size, share, segmentation and regional forecast.
$976M market · 2025 base year
View reportNon-pneumatic Anti-shock Garment Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportNon-perforated Impression Trays Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportNon-Pattern Lens Edger Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.